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In the 20 years since the Federal Policy for the Protection of Human Subjects (also known as the “Common Rule”) was last updated, the field of research has evolved con-
siderably. Research has become more collaborative, crossing 
scientific and discipline boundaries, and including groups 
who previously were not included owing to presumed vulner-
ability. Scientific knowledge on multiple fronts is proliferating 
rapidly. Data acquisition, collection, ownership, and the shar-
ing and protection of data are both enhanced and complicated 
by advances in technology. New ways to plan and operational-
ize studies and analyze results are developing at a rapid rate. 
In recognition of these changes in the research landscape, 
the Common Rule was updated and published in the Federal 
Register in January 2017 after public comment periods in 
2011 (the Advance Notice of Proposed Rule Making) and 
2015 (the Notice of Proposed Rule Making). The intent of 
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the proposed revisions was to “better protect human subjects 
involved in research, while facilitating valuable research and 
reducing burden, delay, and ambiguity for investigators.”1 
As adopted, the most significant changes to the rule include 
new requirements for informed consent, an option to obtain 
“broad consent” for future studies using stored biospeci-
mens, new categories of exempt research, the elimination of 
continuing review for many low-risk studies, and a general 
requirement to use a single institutional review board (IRB) 
for multi-institution studies.
Early guidance for the Common Rule focused almost 
exclusively on consent and the fair distribution of burdens 
and benefits, and these most recent changes in the Final Rule 
continue in the same vein. Largely absent from both the public 
discourse and the updated guidelines is a recognition of the 
importance of community-level considerations in research. The 
guidelines and requirements established in the Common Rule 
are set on centuries of a sordid past in research, where science 
has been misused to harm and further marginalize those most 
vulnerable and underserved in medicine. Renewed attention 
to the Common Rule in the wake of this update presents an 
opportunity to address some of the many historical and social 
determinants that have led to long-standing health inequities. 
We propose several considerations for IRBs and the research 
community at large that address the interests of communities 
and underscore the principle of justice. Our recommendations 
seek to amend human subjects’ protections that currently over-
emphasize individualism and autonomy to include a collectivist 
ethos that is at least equally as valued in communities of color 
and has been critical in the historical narrative of oppressed 
groups. IRBs and investigators can mitigate heath inequities 
first by recognizing their connection with research, and second 
by better addressing the role and interests of underrepresented 
individuals and their communities in research.
We use the term “health inequities” to refer to systematic 
inequalities in health whereby disadvantaged social groups 
(e.g., the poor, racial or ethnic minorities, women, the mentally 
disabled, and other groups) suffer worse health and decreased 
access to health care compared with more advantaged social 
groups.2,3 The social determinants of health—that is, the cir-
cumstances in which people are born, grow, live, work, age, 
and die—are governed by the distribution of power, wealth, 
and resources, and thus are largely responsible for health 
inequities. Health inequities have been present throughout 
history. In the United States, African American sociologist 
W.E.B. DuBois described and elucidated racial disparities in 
health as early as the 19th century.4 Throughout American 
history, medical experimentation has used individuals from 
underserved and marginalized groups as involuntary research 
subjects, including enslaved Africans, members of the military, 
women and children, prisoners, mentally disabled individuals, 
and other groups vulnerable because of social, economic, or 
medical conditions. Finally, in the aftermath of the U.S. Public 
Health Study at Tuskegee in 1974, the National Commission 
for the Protection of Human Subjects of Biomedical and 
Behavioral Research was created. Since the commission’s 
issuance of the Belmont Report in 1978, those invested in the 
ethical conduct of research have tried to strike the balance 
between the need to advance medical practice and the need for 
ethically sound engagement of diverse groups in research. This 
balance requires thoughtful attention to the Belmont Report’s 
principle of justice, which demands that disadvantaged and 
potentially vulnerable groups are neither inappropriately 
included in nor inappropriately excluded from research.
Much progress has been made. Although the Common 
Rule still references “subjects,” terminology in research eth-
ics more broadly has moved from “subject” to “participant” 
to signal the voluntary nature of research participation. 
Regulations now require that groups considered vulnerable 
or protected—minorities, women, and children—nevertheless 
have the opportunity to participate in and reap the potential 
benefits of research. In the last decade, we have seen growing 
interest in and momentum around patient-centered research 
and engaged research approaches.
Engaged research approaches including community-based 
participatory research, community-engaged research, and 
community–academic partnered participatory research were 
born out of a recognition that only by explicitly including mar-
ginalized groups as partners in research can health inequities 
be reduced.5–7 Such engaged approaches explicitly address con-
cerns that research can and does contribute to social injustice 
and health inequities by unfairly targeting or excluding certain 
groups or by positioning certain populations to be less likely 
to see the benefits of research. As more community–academic 
research is pursued, it is becoming apparent that communities 
are entities that are more than the sum total of the individuals 
within them. The term “community” references a particular 
type of group, characterized by any of a wide variety of human 
associations such as geography, race, ethnicity, gender, illness 
or other health conditions, common culture and traditions, 
shared history, or religion. Communities can also be groups 
with a common interest or cause, or a common economy and 
shared resources.5,8 Communities may or may not have politi-
cal authority (as in the case of some American Indian tribes) 
and will have varying degrees of cohesiveness with regard to 
specific characteristics that define a community.8
Communities are not explicitly protected from harm by 
the Common Rule. Although protections for individuals are 
absolutely essential for the conduct of ethical medical research, 
potential group harms and benefits should also be consid-
ered during both study design and study review processes. 
On the surface, this may seem at odds with the principle of 
Table 1. Major Updates to the Common Rule and Community-Oriented Recommendations for IRBs and Researchers
Common Rule Updated Final Rule Community-Oriented Recommendations 
§46.101(b)
Exempt research





Minor language changes around the meaning 
of vulnerability with respect to coercion and 
undue influence
Encourage/allow flexible membership of the IRB or IRB 
reconstitution to ensure appropriate expertise based on the type 
of research being reviewed.
Revise guidelines for composition, knowledge, expertise, 
flexibility, and training of IRBs to include communities and all 
forms of collaborative research.
§46.109 IRB review of
research
Eliminates continuing review for many studies
§46.111 Criteria for IRB
approval of research
Minor changes to match other major changes Communities should be considered as “subjects” in addition to 
individuals.
“Equitable” selection of subjects should consider issues of 
fairness/justice as well as science. Significant discussion among 
academic researchers and members of affected communities 
may be required to agree on what constitutes fair and just.
§46.112 Review by
institution
No change Encourage institutions and IRBs to consider community-level 
concerns when approving studies.
§46.114 Cooperative
research
Requires use of a single IRB for multisite 
studies in the United States, unless otherwise 
required by law
“Cooperative research” should be interpreted to include 
research done in partnership with communities.




Adds new elements of informed consent
Requires essential elements of informed 
consent to be presented up front
Allows for broad consent for future use of 
stored biospecimens
Include potential risks and benefits to participants’ 
communities in consent forms.
Broaden the concept of informed consent to include a 
process for community consultation and, when appropriate, 
community consent.
Abbreviations: IRB, institutional review board.
autonomy, which is largely interpreted as being applicable 
to individuals. However, consideration of group harms and 
benefits expands the ethical dialogue, addresses expectations 
of a favorable risk–benefit ratio not only for individuals but for 
communities as well, and emphasizes the creation of scientific 
and social value in research.
The updated rule acknowledges community-level concerns 
and the potential for group harms and benefits only with 
respect to American Indian and Alaska Native populations (at 
§ 46.101(f) acknowledging applicability of tribal law in addition 
to the Common Rule). The preamble to the Final Rule notes
that American Indian and Alaska Native communities have
a long history of group consent, tribal consent in addition to
individual consent, and even tribal research review that consid-
ers “community-level protections important for maintaining
the integrity of culturally significant information and prac-
tices.”9 Apart from this, however, the Department of Health
and Human Services missed the opportunity to codify into the 
Final Rule the consideration of community-level concerns as 
fundamental to ethical research for all communities, especially 
those who have been historically marginalized or underserved.
Table 1 summarizes key changes to the Common Rule as 
adopted in the Final Rule, and provides recommendations 
for further IRB guidance that would advance the principle of 
justice in research, recognize the shifting role and expertise 
of stakeholders and communities in research, and establish 
protections that address community concerns. These recom-
mendations are detailed as follows:
• The	most	 significant	 and	useful	 change	would	be	 to
con sider “communities” as “subjects.” Throughout the
text of the Common Rule, wherever there is reference
to “subject/s,” researchers and IRBs should interpret
this to mean not only individuals, but also communities.
This under standing would necessarily mean that, for
IRB approval, consideration of the risks and benefits to
“subjects” should include group harms and benefits.
• The	Final	Rule	includes	a	directive	for	use	of	a	single	IRB.
This increases the relative importance of any given IRB’s
membership. Although the Common Rule directs that
IRBs should include members “with varying backgrounds 
to promote complete and adequate review of research
activities commonly conducted by the institution” and
allows for consultation with “individuals with competence 
in special areas to assist in the review of issues which
require expertise beyond or in addition to that available on 
the IRB,” flexible membership—that is, allowing an IRB to 
reconstitute its voting members as needed—would ensure 
that the IRB is able to conduct an “informed review”
tailored to the type of research being considered.
• “Cooperative	research”	should	be	interpreted	to	include
research done in partnership with communities, not just
multi-institution studies.
• The	“equitable”	selection	of	subjects	should	explicitly
consider issues of justice and fairness as well as science.
A study’s selection process should be designed such that
vulnerable or disadvantaged groups are not exploited, nor 
are they excluded without sufficient scientific justification 
to do so. Benefits and burdens should be distributed fairly, 
with the judgment of “fair” taking into consideration the
views of the affected population(s). Equitable selection of 
participants from communities that experience disparities 
should have a fair process for joint decision making among 
community members and academic partners. Research
teams need to be cognizant of the difficult question of
what constitutes fair and just and be willing to discuss
issues and work out jointly acceptable solutions.5
• All	researchers	should	be	encouraged	to	include	a	state	ment
describing the potential group benefits and group harms in 
the text of informed consent forms. This mea sure would
ensure that researchers thoughtfully consider community-
level impacts in study design and out comes, and would also 
acknowledge individuals’ roles in their larger com munities. 
Explicit acknowledgment of individuals as a part of a
whole is particularly valuable for historically marginalized 
communities, not only for building trust but necessary for 
addressing health inequities.
• Informed	consent	can	and	should	include	a	process	for
community consultation and, when appropriate, commu-
nity consent. Community consultation and consent go
hand in hand. Community consent involves approval
of the research proposal by a governing body with the
authority to enter into binding agreements on behalf of
the community, as is the case for many American Indian
and Alaska Native populations. If there is no formal
governing body, community consent is not possible. In
this case, additional protection can occur in the form of
consultation. Community consultation involves varying
levels of engagement of members of the community of
focus in some or all aspects of the research process. Exam-
ples of consultation include seeking input from local leaders 
(formal or informal) and community members regarding 
the acceptability of specific aspects of the research pro posal, 
the most effective ways to recruit participants from a given 
community, or how to disseminate research findings so as 
to reach the greatest number of people potentially affected.8
The updated Common Rule acknowledges the changing
landscape of research and draws renewed broad atten tion to 
research ethics. However, it does not robustly incor por ate into 
its directives consideration of the social determi nants of health 
or the impact of health inequities. Now is the oppor tune time 
to encourage researchers and IRBs to inter pret the new guide-
lines in ways that are more inclusive, consider protection of 
communities as well as individuals, and broaden the concept 
of informed consent to include group harms and benefits.
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